↓ Skip to main content

Dove Medical Press

Article Metrics

Cost analysis of initial highly active antiretroviral therapy regimens for managing human immunodeficiency virus-infected patients according to clinical practice in a hospital setting

Overview of attention for article published in Therapeutics and Clinical Risk Management, December 2013
Altmetric Badge

About this Attention Score

  • In the top 25% of all research outputs scored by Altmetric
  • Among the highest-scoring outputs from this source (#34 of 772)
  • High Attention Score compared to outputs of the same age (90th percentile)
  • High Attention Score compared to outputs of the same age and source (90th percentile)

Mentioned by

news
1 news outlet
twitter
5 tweeters

Citations

dimensions_citation
11 Dimensions

Readers on

mendeley
30 Mendeley
Title
Cost analysis of initial highly active antiretroviral therapy regimens for managing human immunodeficiency virus-infected patients according to clinical practice in a hospital setting
Published in
Therapeutics and Clinical Risk Management, December 2013
DOI 10.2147/tcrm.s49428
Pubmed ID
Authors

Giorgio Lorenzo Colombo, Castagna, Sergio Di Matteo, Laura Galli, Giacomo Bruno, Andrea Poli, Stefania Salpietro, Alessia Carbone, Andriano Lazzarin

Abstract

In the study reported here, single-tablet regimen (STR) versus (vs) multi-tablet regimen (MTR) strategies were evaluated through a cost analysis in a large cohort of patients starting their first highly active antiretroviral therapy (HAART). Adult human immunodeficiency virus (HIV) 1-naïve patients, followed at the San Raffaele Hospital, Milan, Italy, starting their first-line regimen from June 2008 to April 2012 were included in the analysis.

Twitter Demographics

The data shown below were collected from the profiles of 5 tweeters who shared this research output. Click here to find out more about how the information was compiled.

Mendeley readers

The data shown below were compiled from readership statistics for 30 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
Egypt 1 3%
Unknown 29 97%

Demographic breakdown

Readers by professional status Count As %
Researcher 5 17%
Student > Master 5 17%
Other 4 13%
Student > Bachelor 3 10%
Student > Ph. D. Student 3 10%
Other 6 20%
Unknown 4 13%
Readers by discipline Count As %
Medicine and Dentistry 8 27%
Pharmacology, Toxicology and Pharmaceutical Science 5 17%
Economics, Econometrics and Finance 3 10%
Agricultural and Biological Sciences 3 10%
Immunology and Microbiology 2 7%
Other 5 17%
Unknown 4 13%

Attention Score in Context

This research output has an Altmetric Attention Score of 13. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 24 July 2014.
All research outputs
#832,184
of 9,726,436 outputs
Outputs from Therapeutics and Clinical Risk Management
#34
of 772 outputs
Outputs of similar age
#16,211
of 180,115 outputs
Outputs of similar age from Therapeutics and Clinical Risk Management
#2
of 20 outputs
Altmetric has tracked 9,726,436 research outputs across all sources so far. Compared to these this one has done particularly well and is in the 91st percentile: it's in the top 10% of all research outputs ever tracked by Altmetric.
So far Altmetric has tracked 772 research outputs from this source. They receive a mean Attention Score of 4.1. This one has done particularly well, scoring higher than 95% of its peers.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 180,115 tracked outputs that were published within six weeks on either side of this one in any source. This one has done particularly well, scoring higher than 90% of its contemporaries.
We're also able to compare this research output to 20 others from the same source and published within six weeks on either side of this one. This one has done particularly well, scoring higher than 90% of its contemporaries.